Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging
- PMID: 29927634
- PMCID: PMC6350484
- DOI: 10.1259/bjr.20180177
Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging
Abstract
Objective:: To compare the diagnostic performance of non-contrast liver MRI to whole MRI using gadoxetic acid for detection of recurrent hepatocellular carcinoma (HCC) after hepatectomy.
Methods:: This retrospective study analyzed 483 patients who underwent surveillance with liver MRI after hepatectomy for HCC (median time interval, 7.7 months). Non-contrast MRI set (T1- and T2 weighted and diffusion-weighted images) and whole MRI set (gadoxetic acid-enhanced and non-contrast MRI) were analyzed independently by two observers. Receiver operating characteristic analysis was used (with the observers' individual observations and consensus) to detect recurrent HCC. The accuracy, sensitivity, and specificity were calculated.
Results:: A total of 113 patients had 197 recurrent HCCs on first follow-up MRI. Although non-contrast MRI had fairly high sensitivity for recurrent HCC, there were significant differences in sensitivity (94.7% vs 99.1%, p = 0.025) and accuracy (97.5% vs 99.2%, p = 0.021) between the two image sets (per-patients base analysis). However, in patients followed for ≥1 year after surgery, the diagnostic performance of non-contrast MRI and whole MRI were not significantly different (p > 0.05).
Conclusion:: Non-contrast MRI may serve as an alternative follow-up method which can potentially replace whole MRI at least in selected patients followed up ≥1 year after surgery who have relatively lower risk of HCC recurrence.
Advances in knowledge:: There is no consensus regarding the ideal imaging modality or follow-up interval after resection of HCC. Non-contrast MRI had comparable performance to that of gadoxetic acid-enhanced MRI in the detection of HCC recurrence during surveillance ≥1 year after surgery.
Figures




Similar articles
-
Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.Eur Radiol. 2020 Jan;30(1):186-194. doi: 10.1007/s00330-019-06351-0. Epub 2019 Aug 1. Eur Radiol. 2020. PMID: 31372783
-
Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.Radiology. 2015 Jan;274(1):149-60. doi: 10.1148/radiol.14140141. Epub 2014 Sep 5. Radiology. 2015. PMID: 25203131
-
Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging?Invest Radiol. 2010 Nov;45(11):740-6. doi: 10.1097/RLI.0b013e3181e943a7. Invest Radiol. 2010. PMID: 20644488
-
Management of sub-centimeter recurrent hepatocellular carcinoma after curative treatment: Current status and future.World J Gastroenterol. 2018 Dec 14;24(46):5215-5222. doi: 10.3748/wjg.v24.i46.5215. World J Gastroenterol. 2018. PMID: 30581270 Free PMC article. Review.
-
Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging.Eur Radiol. 2020 Jan;30(1):370-382. doi: 10.1007/s00330-019-06369-4. Epub 2019 Aug 5. Eur Radiol. 2020. PMID: 31385048 Free PMC article.
Cited by
-
Deep Learning-Accelerated Non-Contrast Abbreviated Liver MRI for Detecting Malignant Focal Hepatic Lesions: Dual-Center Validation.Korean J Radiol. 2025 Apr;26(4):333-345. doi: 10.3348/kjr.2024.0862. Korean J Radiol. 2025. PMID: 40150922 Free PMC article.
-
Advanced Imaging of Hepatocellular Carcinoma: A Review of Current and Novel Techniques.J Gastrointest Cancer. 2024 Dec;55(4):1469-1484. doi: 10.1007/s12029-024-01094-8. Epub 2024 Aug 19. J Gastrointest Cancer. 2024. PMID: 39158837 Review.
-
Accuracy of Non-Contrast MRI for the Detection of Hepatocellular Carcinoma: A systematic review and meta-analysis.Pak J Med Sci. 2022 Mar-Apr;38(3Part-I):743-750. doi: 10.12669/pjms.38.3.5142. Pak J Med Sci. 2022. PMID: 35480538 Free PMC article. Review.
-
Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System.J Clin Exp Hepatol. 2019 Sep-Oct;9(5):625-651. doi: 10.1016/j.jceh.2019.07.005. Epub 2019 Aug 6. J Clin Exp Hepatol. 2019. PMID: 31695253 Free PMC article. Review.
-
Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging.Eur Radiol. 2021 Aug;31(8):5615-5628. doi: 10.1007/s00330-020-07637-4. Epub 2021 Feb 1. Eur Radiol. 2021. PMID: 33523304 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical